Durable clinical responses observed from non-Hodgkin lymphoma patients treated with autologous CAR-T cells targeting CD19.
Publication
, Conference
Liu, Y; Zhu, B; Jia, Q; He, F; Fang, H; Chen, J; Shi, Z; Jin, T; Wei, B; Xie, R; Li, Q-J; Wang, P
Published in: Journal of Clinical Oncology
May 20, 2018
Duke Scholars
Published In
Journal of Clinical Oncology
DOI
EISSN
1527-7755
ISSN
0732-183X
Publication Date
May 20, 2018
Volume
36
Issue
15_suppl
Start / End Page
3045 / 3045
Publisher
American Society of Clinical Oncology (ASCO)
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Liu, Y., Zhu, B., Jia, Q., He, F., Fang, H., Chen, J., … Wang, P. (2018). Durable clinical responses observed from non-Hodgkin lymphoma patients treated with autologous CAR-T cells targeting CD19. In Journal of Clinical Oncology (Vol. 36, pp. 3045–3045). American Society of Clinical Oncology (ASCO). https://doi.org/10.1200/jco.2018.36.15_suppl.3045
Liu, Yarong, Bo Zhu, Qingzhu Jia, Feng He, Hongliang Fang, Jing Chen, Zixiao Shi, et al. “Durable clinical responses observed from non-Hodgkin lymphoma patients treated with autologous CAR-T cells targeting CD19.” In Journal of Clinical Oncology, 36:3045–3045. American Society of Clinical Oncology (ASCO), 2018. https://doi.org/10.1200/jco.2018.36.15_suppl.3045.
Liu Y, Zhu B, Jia Q, He F, Fang H, Chen J, et al. Durable clinical responses observed from non-Hodgkin lymphoma patients treated with autologous CAR-T cells targeting CD19. In: Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2018. p. 3045–3045.
Liu, Yarong, et al. “Durable clinical responses observed from non-Hodgkin lymphoma patients treated with autologous CAR-T cells targeting CD19.” Journal of Clinical Oncology, vol. 36, no. 15_suppl, American Society of Clinical Oncology (ASCO), 2018, pp. 3045–3045. Crossref, doi:10.1200/jco.2018.36.15_suppl.3045.
Liu Y, Zhu B, Jia Q, He F, Fang H, Chen J, Shi Z, Jin T, Wei B, Xie R, Li Q-J, Wang P. Durable clinical responses observed from non-Hodgkin lymphoma patients treated with autologous CAR-T cells targeting CD19. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2018. p. 3045–3045.
Published In
Journal of Clinical Oncology
DOI
EISSN
1527-7755
ISSN
0732-183X
Publication Date
May 20, 2018
Volume
36
Issue
15_suppl
Start / End Page
3045 / 3045
Publisher
American Society of Clinical Oncology (ASCO)
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences